Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Mohar

Showing results (141-150 of 193) with videos related to

Pageof 20
Sort By:
Cancer Treatment and Research Communications|March 10, 2026
Corrigendum to 'Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer' [Cancer Research and Treatment Communications 46 (2026) 101112]Jesus Edgardo Hernandez-Hernandez, César Octavio Lara-Torres, Alejandro Aranda-Gutiérrez, et al.
Frontiers in Oncology|November 7, 2025
The role of complementary lymphadenectomy in patients with incidental endometrial cancerSalim Abraham Barquet-Muñoz, Pamela Martínez-Alpizar, Andrea Ramirez, et al.
The Oncologist|March 2, 2018
Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant ChemotherapyPaula Cabrera-Galeana, Wendy Muñoz-Montaño, Fernando Lara-Medina, et al.
Cancer|September 20, 2014
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in MexicoCynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, et al.
Breast Cancer Research and Treatment|May 19, 2016
Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapyCynthia Villarreal-Garza, Juan Enrique Bargallo-Rocha, Enrique Soto-Perez-de-Celis, et al.
Tobacco Induced Diseases|February 6, 2015
Medical care costs incurred by patients with smoking-related non-small cell lung cancer treated at the National Cancer Institute of MexicoOscar Arrieta, Roger Humberto Quintana-Carrillo, Gabriel Ahumada-Curiel, et al.
Advances in Therapy|March 6, 2015
Cost-effectiveness of the 21-gene breast cancer assay in MexicoJuan Enrique Bargalló-Rocha, Fernando Lara-Medina, Victor Pérez-Sánchez, et al.
Journal of Cancer Survivorship : Research and Practice|April 23, 2026
Five-year longitudinal changes in social, economic, and psychosocial wellbeing among young women with breast cancer in MexicoCynthia Villarreal-Garza, Fernanda P Pons-Faudoa, Alejandra Platas, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II studyAlfonso Dueñas-González, Lucely Cetina-Perez, Carlos Lopez-Graniel, et al.
Journal of Surgical Oncology|June 14, 2017
The impact of the use of intraoperative radiotherapy on costs, travel time and distance for women with breast cancer in the Mexico City Metropolitan AreaJuan Enrique Bargallo-Rocha, Enrique Soto-Perez-de-Celis, Francisco Javier Picó-Guzmán, et al.
Pageof 20

Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
Cancer Treatment and Research Communications|March 10, 2026
Corrigendum to 'Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer' [Cancer Research and Treatment Communications 46 (2026) 101112]Jesus Edgardo Hernandez-Hernandez, César Octavio Lara-Torres, Alejandro Aranda-Gutiérrez, et al.
Frontiers in Oncology|November 7, 2025
The role of complementary lymphadenectomy in patients with incidental endometrial cancerSalim Abraham Barquet-Muñoz, Pamela Martínez-Alpizar, Andrea Ramirez, et al.
The Oncologist|March 2, 2018
Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant ChemotherapyPaula Cabrera-Galeana, Wendy Muñoz-Montaño, Fernando Lara-Medina, et al.
Cancer|September 20, 2014
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in MexicoCynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, et al.
Breast Cancer Research and Treatment|May 19, 2016
Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapyCynthia Villarreal-Garza, Juan Enrique Bargallo-Rocha, Enrique Soto-Perez-de-Celis, et al.
Tobacco Induced Diseases|February 6, 2015
Medical care costs incurred by patients with smoking-related non-small cell lung cancer treated at the National Cancer Institute of MexicoOscar Arrieta, Roger Humberto Quintana-Carrillo, Gabriel Ahumada-Curiel, et al.
Advances in Therapy|March 6, 2015
Cost-effectiveness of the 21-gene breast cancer assay in MexicoJuan Enrique Bargalló-Rocha, Fernando Lara-Medina, Victor Pérez-Sánchez, et al.
Journal of Cancer Survivorship : Research and Practice|April 23, 2026
Five-year longitudinal changes in social, economic, and psychosocial wellbeing among young women with breast cancer in MexicoCynthia Villarreal-Garza, Fernanda P Pons-Faudoa, Alejandra Platas, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II studyAlfonso Dueñas-González, Lucely Cetina-Perez, Carlos Lopez-Graniel, et al.
Journal of Surgical Oncology|June 14, 2017
The impact of the use of intraoperative radiotherapy on costs, travel time and distance for women with breast cancer in the Mexico City Metropolitan AreaJuan Enrique Bargallo-Rocha, Enrique Soto-Perez-de-Celis, Francisco Javier Picó-Guzmán, et al.
Pageof 20